Theriva Biologics TOVX
NYSE TOVX
$0.20 -0.01 (-5.45%)
As of: Oct 21, 2026 · 3:59 PM EDT

Theriva Biologics (TOVX) Receivables (2010 - 2012)

Updated

Theriva Biologics (TOVX) recorded Receivables of $122,000 in Q3 2012, down 75.3% from $494,851 a year earlier and down 50.2% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Receivables (2010 - 2012) Analysis & Trends

At the end of FY2011, Theriva Biologics reported Receivables of $405,000, up 19.5% from FY2010.

  • Across earlier years, Receivables came in at $339,000 in FY2010.
  • Per Business Quant, the preceding three quarters came in at $245,000 (Q2 2012), $440,000 (Q1 2012) and $405,000 (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Theriva Biologics 9.11 Mn -37.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 122,000.00
Jun 30, 2012 245,000.00
Mar 31, 2012 440,000.00
Dec 31, 2011 405,000.00
Sep 30, 2011 494,851.00
Jun 30, 2011 444,664.00
Dec 31, 2010 339,000.00
API Access

Theriva Biologics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TOVX&period=max&api_key=YOUR_API_KEY